Head-to-head · Cost-Efficiency Index
Rejuve Meds vs Teleios Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rejuve Meds
Patients comfortable prepaying or financing a full 12-month commitment upfront in exchange for the lowest headline rate.
Visit Rejuve MedsTeleios Health
Shoppers comfortable calling or messaging before committing, since public pricing detail is minimal.
Visit Teleios HealthThe verdict
Rejuve Meds and Teleios Health tie on the Cost-Efficiency Index at 65/100, so neither wins outright on the numbers. For most shoppers we'd start with Rejuve Meds (ranked #167, a hair above #170) — Patients comfortable prepaying or financing a full 12-month commitment upfront in exchange for the lowest headline rate. But Teleios Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rejuve Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rejuve Meds | Teleios Health |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 65/100 |
| Semaglutide / mo | $85/mo (compounded oral) | $99/mo (all doses, compounded) |
| Tirzepatide / mo | $85/mo (12-month plan, compounded oral) | Not disclosed |
| Semaglutide / yr (modeled) | $1,020 | $1,188 |
| Tirzepatide / yr (modeled) | $1,020 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #167 | #170 |
Rejuve Meds
65/100Where the value is
- Offers both injectable and dissolvable oral tablet formats for semaglutide and tirzepatide
- No insurance required, free shipping
- Claims a 14.9% average weight loss within a year based on GLP-1 use
The tradeoffs
- Headline '$85' price is a 12-month-prepay-equivalent rate, not a real monthly price -- the true month-to-month cost is undisclosed
- No medical director named anywhere on the site
Teleios Health
65/100Where the value is
- Advertises a low $99/mo headline starting price, undercutting most compounded-GLP-1 competitors on paper
- Explicitly brands itself as 'physician-led,' setting an expectation of clinician oversight
- Discloses the standard compounded-medication FDA disclaimer up front rather than burying it
The tradeoffs
- No dose amount, drug, or inclusion breakdown is published for the $99/mo figure
- No visit fee, membership fee, or shipping fee disclosure could be found anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.